FDA Investigating Whether Diabetes Drug Metformin Contains Probable Carcinogen

first_imgInternationalLifestyleNews FDA Investigating Whether Diabetes Drug Metformin Contains Probable Carcinogen  by: – December 16, 2019 Share A drug often prescribed to diabetes patients is being investigated for traces of a probable carcinogen after it was recalled abroad, the US Food and drug administration said.Health officials are investigating whether Metformin sold in the US contains NDMA, a contaminant that has been linked to cancer, the FDA said in a news release.Testing will also look into whether the amount of NDMA in the drug is above the acceptable daily intake limit of 96 nanograms.The drug is used to control high blood sugar in patients with type 2 diabetes.The FDA told patients to continue to use Metformin while the investigation continues because there are no alternative medications that treat type 2 diabetes the same way.As part of our continuing investigation, the FDA is investigating whether Metformin in the US market contains NDMA impurity, and whether it is above the acceptable daily intake limit of 96 nanograms.Everyone is exposed to some level of NDMA, which is a common contaminant found in water and foods including cured and grilled meats, dairy products and vegetables, health officials said.The substance may increase the risk of cancer in people who are exposed to high levels over long periods of time.“A person taking a drug that contains NDMA at-or-below the acceptable daily intake limit every day for 70 years is not expected to have an increased risk of cancer,” the FDA said.Metformin drugs have been recalled in Singapore, and other regulatory agencies in Europe are also investigating the presence of the contaminant.“Based on the information we have available, the levels of NDMA seen outside the u.s. Are within the range that is naturally occurring in some foods and in water,” the FDA said.There have been no recalls of Metformin in the US.“The agency will also work with companies to test samples of Metformin sold in the US and will recommend recalls as appropriate if high levels of NDMA are found,” the FDA said. “if as part of our investigation, Metformin drugs are recalled, the FDA will provide timely updates to patients and health care professionals.”Earlier this year, CVS announced it will be taking Zantac and other Ranitidine heartburn drugs off its shelves after health officials said that the drug contains low levels of NDMA. Share Sharecenter_img 86 Views   no discussions Tweet Sharing is caring!last_img read more

Odion Ighalo’s Future at Watford Hangs in the Balance

first_imgOdion Ighalo looks increasingly likely to quit Watford before the transfer window closes on Tuesday night after he was left out of yesterday’ 0-1  FA Cup loss at Millwall.Watford manager Walter Mazzarri confirmed the club has received official bids for the Super Eagles striker with Chinese club in the forefront of the chase.It was understood Watford is demanding for as much as 25 million pounds for the 27-year-old and Shanghai Shenhua has tabled an offer of 15 million pounds.Ighalo has also been linked with another Premier League club, West Bromwich Albion, who are shopping for another striker following the move of Saido Berahino to Stoke City.Nigeria stars John Mikel Obi and Chinedu Obasi are among the players who have moved this month to China.They join other compatriots like Obafemi Martins and Anthony Ujah in the money spinning Chinese Super League. Share this:FacebookRedditTwitterPrintPinterestEmailWhatsAppSkypeLinkedInTumblrPocketTelegramlast_img read more

Syracuse football recruiting: 3-star running back Jo-El Shaw becomes 16th member of 2016 class

first_img Related Stories Syracuse football recruiting: 3-star Michael Clark becomes 4th offensive lineman in 2016 classSyracuse football recruiting: 3-star athlete Moe Neal commits to Class of 2016Syracuse football recruiting: 2016 athlete Sean Riley flips from Arizona to SyracuseSyracuse football reportedly hires former Onondaga Central High School RB Mike Hart as running backs coachRobert Washington reportedly decommitted due to trust issues with SU coaching staff Comments AdvertisementThis is placeholder textShaw is the only running back commit in the class, although he joins Moe Neal and Sean Riley who could both be used either as a running back or as a slot receiver. Three-star running back Robert Washington was previously committed to SU but reportedly decommitted last summer due to trust issues with the prior coaching staff.The 6-foot-1, 215-pound running back from Woodland Hills (Pennsylvania) High School is ranked with three stars and as the 76th best running back in the 2016 class, according to 247Sports.com’s composite rankings. He also had offers from Pittsburgh, Temple and Bowling Green, Babers’ prior school.Shaw is now the second commit from Pennsylvania, joining Michael Clark, who committed to Syracuse less than two hours before Shaw. Class of 2016 running back Jo-El Shaw verbally committed to Syracuse, he announced in a tweet on Saturday afternoon. He is the 16th member of the Orange’s 2016 class and ninth player to commit since Dino Babers was hired on Dec. 5.Shaw was previously committed to Western Michigan until about two weeks ago. Newly hired SU running backs coach Mike Hart used to work at WMU. Earlier this week, Shaw received an in-home visit from Hart and co-offensive coordinator Sean Lewis. He is also taking an official visit to Syracuse this weekend.center_img Published on January 23, 2016 at 3:53 pm Contact Paul: [email protected] | @pschweds Facebook Twitter Google+last_img read more